In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-22 of 22 for your search:
Drug:  fluorine F 18 fluorothymidine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: FLT101, NCT00847509
2.

Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: P020907, NCT00236275
3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OSI3926g, ML20773, NCT00453362
4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N057K, N057K, NCT00553150
5.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 9420-04, 2004-033, NCT00624728
6.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-005393-73, 06159, NCT00568841
7.

Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 200801758, 1R21CA130281, NCT00721799
8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000615035, P30CA015083, MC057M, 08-002166, NCI-2009-01193, MAYO-MC057M, MAYO-08-002166, NCT00757549
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 35 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: MK-0000-139, 2009_692, NCT01015131
10.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 200906786, NCT01075412
11.

Phase: Phase I
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: D0008186, NCT00553748
12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 089025, NCT00859118
13.

Phase: Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0658, NCT01143779
14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-09904, CO-09904, 8477, NCT01243359
15.

Phase: Phase I
Type: Treatment
Status: Temporarily closed
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: MCC 13222, NCI-2010-02340, P30CA016059, NCT01283178
16.

Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UW-6230, 6230, NCI-7223, 7223, NCT00276770
17.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HCI21897, NCT00694096
18.

Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-142, NCT00832598
19.

Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2007-006265-32, NCT00850278
20.

Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 to 89
Sponsor: NCI, Other
Protocol IDs: 09-060, R21CA137896-01A1, NCT00979810
21.

Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 01109, NCT01018251
22.

Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-169, NCT01243619
New Search